Drug safety and tolerability in prophylactic migraine treatment

László VécseiUniversity of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary+36 62 545348; +36 62 545597; [email protected];University of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary;MTA – SZTE Neuroscience Research Group, Semmelweis u. 6, H-6725 Szeged, Hungary

, MD PhD DSc (Member of the Hungarian Academy of Sciences) ,

Zsófia MajláthUniversity of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary

, MD (Resident in Clinical Neurology) ,

Délia SzokUniversity of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary

, MD PhD (Associate Professor of Clinical Neurology) ,

Anett CsátiUniversity of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary

, MD PhD (Resident in Clinical Neurology) &

János TajtiUniversity of Szeged, Department of Neurology, Semmelweis u. 6, H-6725 Szeged, Hungary

, MD PhD (Associate Professor of Clinical Neurology) (Head of the Department of Neurology) (Associate Professor of Clinical Neurology) (Head of the Department of Neurology)

Drug safety and tolerability in prophylactic migraine treatment

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Drug safety and tolerability in prophylactic migraine treatment

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date